LONDON, March 1, 2010 /PRNewswire-FirstCall/ -- Merck, the global
pharmaceutical and chemical company, announced it is to acquire all
outstanding shares of Millipore, the US life sciences company, for US$ 107
per share in cash, or a total transaction value, including net debt, of
approximately E
http://digg.com/u1Ocd2
No comments:
Post a Comment